High-dose experimental vaccine for herpes zoster

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Jan 2026: Trial started, NCT07400003
  2. 10 Feb 2026: Trial registered, NCT07400003

The trials

NCT07400003: Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

State
Under way
Phase
Phase 1 and Phase 2
People
519 planned
Started
6 Jan 2026
Primary completion
31 May 2026
Arms
High-dose group
Results
None posted
  1. 6 Jan 2026: Trial started
  2. 10 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.